“…The OMM was developed in healthy adults and validated against the HE clamp using data from a 7-h OGTT, but some implementations of OMM have been applied in adults with type 2 diabetes and adolescent cohorts [ 30 , [38] , [39] , [40] , [41] , [42] , [43] ]. estimates from shorter OGTT/OMM protocols have been validated in adult populations without type 2 diabetes [ 30 , 38 ], lean to obese adolescents [ 40 ], and adolescent girls [ 42 , 43 ]. However, insulin resistance (IR) alters the glucose-insulin dynamics represented by OMM, and protocol duration dependence of OMM estimates has not been rigorously assessed in populations expressing diverse metabolic phenotypes.…”